Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Apolipoprotein D anticorps

L’anticorps Souris Monoclonal anti-Apolipoprotein D a été validé pour ELISA. Il convient pour détecter Apolipoprotein D dans des échantillons de Humain. Il y a 3+ publications disponibles.
N° du produit ABIN6963942

Aperçu rapide pour Apolipoprotein D anticorps (ABIN6963942)

Antigène

Voir toutes Apolipoprotein D (APOD) Anticorps
Apolipoprotein D (APOD)

Reactivité

  • 37
  • 21
  • 20
  • 15
  • 3
Humain

Hôte

  • 47
  • 7
  • 2
  • 2
Souris

Clonalité

  • 49
  • 9
Monoclonal

Conjugué

  • 30
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Apolipoprotein D est non-conjugé

Application

  • 42
  • 19
  • 15
  • 13
  • 13
  • 10
  • 9
  • 9
  • 3
  • 2
  • 2
  • 1
ELISA

Clone

D544
  • Specificité

    Apolipoprotein D

    Purification

    Purified from in vitro cultures by protein G affinity chromatography.

    Immunogène

    Recombinant human apoD

    Isotype

    IgG1
  • Indications d'application

    For quantification of apoD in serum/ plasma samples and cell culture supernatants using ELISA. D544 is recommended as coating mAb in combination with detection mAb D263 .

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.

    Date de péremption

    18 months
  • Kuiperij, Hondius, Kersten, Versleijen, Rozemuller, Greenberg, Schreuder, Klijn, Verbeek: "Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy." dans: Neuropathology and applied neurobiology, Vol. 46, Issue 5, pp. 431-440, (2020) (PubMed).

    Herzig, Leppäluoto, Jokelainen, Meugnier, Pesenti, Selänne, Mäkelä, Ahola, Jämsä, Vidal, Keinänen-Kiukaanniemi: "Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes." dans: Scientific reports, Vol. 7, Issue 1, pp. 11267, (2019) (PubMed).

    Braesch-Andersen, Beckman, Paulie, Kumagai-Braesch: "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma." dans: PLoS ONE, Vol. 9, Issue 12, pp. e115180, (2016) (PubMed).

  • Antigène

    Apolipoprotein D (APOD)

    Autre désignation

    apoD

    ID gène

    347

    Pathways

    Platelet-derived growth Factor Receptor Signaling
Vous êtes ici:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!